Denzapine 50mg/ml Oral Suspension - company led recall
Britannia Pharmaceuticals Ltd has issued a company-led drug alert for Denzapine 50mg/ml Oral Suspension (CLDA (18)A/03)
Product information
CLDA number
CLDA (18)A/03
MDR number
42-05/18
Company name
Britannia Pharmaceuticals Ltd
Product description
Denzapine 50mg/ml Oral Suspension
PL04483/0071
Batch number/expiry
| Batch No. | Expiry date |
|---|---|
| Batch A0515 | Exp 06/2018 |
| Batch A1046 | Exp 08/2018 |
| Batch A2074 | Exp 10/2018 |
Brief description of the problem
Britannia Pharmaceuticals Ltd is recalling the above batches because of increased crystallisation of the active ingredient which may affect delivery of the full dose. The company is also issuing a letter to Healthcare Professionals reminding them of the shaking instructions given in the Summary of Product Characteristics and Patient information Leaflet.
Company contact for stock enquiries
Britannia Pharmaceuticals Ltd customer services.
Tel: 01189 209 577
customerservices@britannia-pharm.com
Company contact for medical information
Britannia Pharmaceuticals Ltd Medical Information Service.
Tel: 01483 920 763
Published 25 June 2018